N/A
N=146
The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department
Hypertension · Emergencies · Asymptomatic Conditions
Bottom Line
View on ClinicalTrials.gov: NCT02534324 ↗Enrolled (actual)
146
Serious AEs
0.7%
Results posted
Mar 2016
Primary outcome: Primary: Number of Participants Who Died Within 7 Days After Discharge From the Emergency Department — 0; 0 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Antihypertensive meds (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Chulalongkorn University
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Died Within 7 Days After Discharge From the Emergency Department |
0; 0 | — |
| SECONDARY Number of Participants Who Had Major Hypertensive-related Events After Discharge From the Emergency Department |
1; 0 | 0.49 |
| SECONDARY Systolic Blood Pressure at Follow-up |
153.7; 160.9 | 0.15 |
Summary
The current guideline of asymptomatic severe hypertension (ASH) treatment in emergency department (ED) recommends through low level of evidence that the patients should not be rapidly decreased their BP in ED but instead receive oral antihypertensive treatment and close outpatient follow-up is needed. Unfortunately, there was some ambiguity in the time point of BP measurement in ED described in the past literature because high BP on ED admission may significantly decrease within hours without any medications. The importance of pre-ED discharge BP, which can still be critically high, that may affect the follow-up outcome has never been investigated. The study aim of this study is to evaluate the physicians' treatment strategies as well as immediate clinical outcomes between patients with severely- and moderately-elevated pre-discharge BP after management of ASH its in ED during the recent recommendation. The secondary outcome is to compare the BP at follow-up in these two groups.
Eligibility Criteria
Inclusion Criteria
- Adult patients ≥18 years old
- Systolic BP (SBP) greater or equal to 180 mmHg
- Diastolic BP (DBP) ≥ 100 mmHg
Exclusion Criteria
- Acute end-organ damage related to severe hypertension that required rapid intravenous antihypertensive drugs for acute treatment involving cardiovascular (acute chest pain, heart failure, acute coronary syndromes, acute aortic syndromes), renal (acute kidney injury), ocular (retinal hemorrhage or hypertensive retinopathy) and central nervous system (seizure, acute cerebrovascular diseases, hypertensive encephalopathy)
- Hypertension caused by medical toxicology (e.g. use of sympathomimetic drugs (amphetamine and its derivatives), alcohol withdrawal syndrome
- Significantly decreased renal function (serum creatinine ≥ 1.5 mg/dL or creatinine clearance ≤ 30 ml/min)
- Pregnant women
- Moderate to severe pain (pain score on visual analog scale ≥ 5 centimeters out of 10)
- BP decrease to less than 180 mmHg after 10-minute bed rest without any medical treatment
- Having concurrent medical conditions that needed hospitalization.
Data sourced from ClinicalTrials.gov (NCT02534324). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.